...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A sensitive LC-MS/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers
【24h】

A sensitive LC-MS/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers

机译:一种敏感的LC-MS / MS / MS方法,用于在人血浆中存在7-羟吡啶吡啶和哌啶硫氧化物的存在及其在中国健康志愿者的比较生物等效研究中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A robust and highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of pericyazine in human plasma. The plasma sample was alkalized with sodium hydroxide solution and handled by liquid-liquid extraction with ethyl acetate after adding perphenazine as an internal standard (IS). The analytes were separated on an Ultimate (TM) AQ-C18 analytical column at 40 degrees C, with a gradient elution consisting of A (aqueous phase: 5 mM ammonium acetate buffer solution containing 0.1% formic acid) and B (organic phase: acetonitrile) at a flow rate of 0350 mL/min. The detection was conducted on an API 4000 tandem mass spectrometer coupled with electrospray ionization (ESI) source in positive ion mode. The multiple reaction monitoring (MRM) transitions, m/z 366.5 > 142.4 for pericyazine, m/z 382.5 > 142.4 for its 7-hydroxy and sulphoxide metabolites and m/z 404.3> 171.3 for IS were chosen to achieve high selectivity in the simultaneous analyses. The method exhibited great improvement in sensitivity (LLOQ of 0.021 ng/mL) and good linearity over the concentration range of 0.021-9.90 ng/mL. The intra- and inter-day precision, accuracy, and stability results were within the acceptable limits and no matrix effect was observed. This method was successfully applied in a bioequivalence study to evaluate the pharmacokinetics in 20 healthy male Chinese volunteers. Additional exploratory analyses of 7-hydroxy and sulphoxide metabolites of pericyazine in the same samples suggest that the unchanged drug is predominant in the plasma and suitable for the bioequivalence comparison after a single oral administration of 10 mg pericyazine. (C) 2016 Elsevier B.V. All rights reserved.
机译:开发了一种稳健且高敏感的液相色谱 - 串联质谱(LC-MS / MS)方法并验证用于测定人血浆中蛇氨酸。将血浆样品用氢氧化钠溶液碱化,并通过液 - 液萃取用乙酸乙酯加入乙酸乙酯作为内标(是)。将分析物在40℃下在最终(TM)AQ-C18分析柱上分离,具有由(含有0.1%甲酸的水相:5mM乙酸铵缓冲液)和B的梯度洗脱(有机相:乙腈)以0350ml / min的流速。在耦合的API 4000串联质谱仪上进行检测,其耦合在正离子模式中的电喷雾电离(ESI)源。对于其7-羟基和硫氧化物代谢物和M / Z 404.3> 171.3的多丙氨酸,M / Z 36.5> 142.4的多重反应监测(MRM)过渡,M / Z 366.5> 142.4。对于同时的选择分析。该方法表现出浓度(LLOQ为0.021ng / ml)的显着改善,浓度范围为0.021-9.90ng / ml的良好线性。在日内和日间精确,准确性和稳定性结果都在可接受的限度内,并且没有观察到基质效应。该方法成功地应用于生物等效性研究中,以评估20名健康男性中国志愿者的药代动力学。在同一样品中近丙氨酸的7-羟基和硫氧化胺代谢物的额外探索性分析表明,不变的药物在血浆中主要是占主导地位,并且适用于10毫克口服施用于10毫克近丙嗪后的生物等效比较。 (c)2016 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号